BN Business News
Şirketinizi ekleyin →
Bu çeviri hazırlanıyor. Bu süre içinde İngilizce orijinal sürümü gösteriyoruz.

İş dünyası · 14.10.20101 dk okuma

Draft Guidance for Industry: Early Clinical Trials With Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information; Availability

Yerel otomatik çeviri · Kaynağın orijinal dili

Özet

The Food and Drug Administration (FDA) is announcing the availability of a draft document entitled "Guidance for Industry: Early Clinical Trials with Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information" dated September 2010. The draft guidance provides investigational new drug application (IND) sponsors with recommendations on the submission of INDs for early clinical trials with live biotherapeutic products (LBPs).

Kaynağın orijinal dili: Federal Register — Health and Human ServicesOrijinal duyuruyu açın →